Login / Signup

Is radiomic MRI a feasible alternative to OncotypeDX® recurrence score testing? A systematic review and meta-analysis.

Matthew G DaveyM S DaveyÉ J RyanMichael R BolandP F McAnenaA J LoweryM J Kerin
Published in: BJS open (2021)
Radiomic tumour analysis is comparable to RS in differentiating patients into clinically relevant subgroups. For patients requiring MRI, radiomics may complement and enhance RS for prognostication and therapeutic decision making in ER+ breast cancer.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • contrast enhanced
  • newly diagnosed
  • magnetic resonance imaging
  • peritoneal dialysis
  • prognostic factors
  • computed tomography
  • young adults